David P. Roe bought Serina Therapeutics Inc (NYSE MKT: SER)
David P. Roe (R-TN), a U.S. Representative, has disclosed 1 trade in Serina Therapeutics Inc (SER) since 2019, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: David P. Roe bought $1,000 - $15,000 of Serina Therapeutics Inc (NYSE MKT: SER) on June 24, 2019. Since that trade, SER is down -98.55% against the S&P 500 up +179.04%, an outperformance of -277.59%.
Data updated
David P. Roe's SER trades vs the price
SER is down -98.55% since David P. Roe bought on June 24, 2019, versus +179.04% for the S&P 500.
Performance since this trade
All David P. Roe SER trades
David P. Roe & SER trading FAQ
Is it legal for David P. Roe to trade Serina Therapeutics Inc (SER) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Serina Therapeutics Inc (SER), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did David P. Roe buy SER?
David P. Roe disclosed a purchase of $1,000 - $15,000 of Serina Therapeutics Inc (SER) on June 24, 2019, according to public STOCK Act filings.
How has SER performed since David P. Roe's trade?
Since David P. Roe bought SER on June 24, 2019, the stock is down -98.55%, versus +179.04% for the S&P 500 over the same period, an outperformance of -277.59%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SER trades?
Quantellect tracks every disclosed congressional trade in Serina Therapeutics Inc (SER) on the Serina Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
David P. Roe's SER tradesAll congressional filings for Serina Therapeutics IncDavid P. Roe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.